Results 151 to 160 of about 14,257 (250)

Identification of “dual-site”-binding diarylpyrimidines targeting both NNIBP and the NNRTI adjacent site of the HIV-1 reverse transcriptase

, 2022
Da Feng, Xiaofang Zuo, Fabao Zhao, Hao Lin, Jiaojiao Dai, Yangyin Sun, Erik De Clercq, Christophe Pannecouque, Dongwei Kang, Xinyong Liu, Peng Zhan   +10 more
openalex   +1 more source

Impact of V179D/E mutations on antiretroviral therapy outcomes in people living with HIV-1: a 3-year retrospective study. [PDF]

Front Cell Infect Microbiol
Lv S, Lan Y, Li Q, Ling X, Li J, Wen C, Li Y, Chen J, Chen X, Cai W, Tang X, Li L.   +11 more
europepmc   +1 more source

Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens [PDF]

, 2010
Weerawat Manosuthi, Wiroj Mankatitham, Aroon Lueangniyomkul, Wisit Prasithsirikul, Preecha Tantanathip, Busakorn Suntisuklappon, Anongnuch Narkksoksung, Samruay Nilkamhang, Somnuek Sungkanuparph   +8 more
openalex   +1 more source

Switch to Fixed Dose of Doravirine, Lamivudine, Tenofovir Disoproxil Fumarate Versus Bictegravir, Emtricitabine, and Tenofovir Alafenamide Fumarate in Virologically Suppressed Adults on Efavirenz-Based Regimens: 48-Week Results of a Real-world, Prospective, Observational Cohort Study. [PDF]

Open Forum Infect Dis
Li A, Li Z, Li J, Gao Y, Dai L, Liu A, Zhang H, Wang X, Wu L, Yao Y, Liu L, Ye J, Sun L.   +12 more
europepmc   +1 more source

Resistance and cross-resistance profile of the diaryltriazine NNRTI and candidate microbicide UAMC01398 [PDF]

, 2016
Kevin K. Ariën, Muthusamy Venkatraj, Johan Míchiels, Jurgen Joossens, Katleen Vereecken, Pieter Van der Veken, Jan Heeres, Hans De Winter, Leo Heyndrickx, Koen Augustyns, Guido Vanham   +10 more
openalex   +1 more source

The impact of the recent HIV non-nucleoside reverse transcriptase inhibitors and nucleoside reverse transcriptase inhibitors-based regimens on metabolic health outcomes: A narrative review. [PDF]

Biochem Biophys Rep
Sedibe A, Sibiya N, Nyakudya T, Gamede M.   +3 more
europepmc   +1 more source

Long-Term Safety and Efficacy of NNRTI Within the Central Nervous System [PDF]

, 2003
Hans Jürgen von Giesen, Hubertus Köller, D Nöcker, Bernhard Haslinger, Gabriele Arendt   +4 more
openalex   +1 more source

Evaluation of Anti-HIV-1 Microbicide Potency of Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) UC781

, 2017
Md. Moyazzem Hossain
openalex   +1 more source

Network Dynamics and Evolutionary Drivers of HIV Drug Resistance in Eastern China, from 2022 to 2024. [PDF]

Viruses
Cao D, Xing H, Feng Y, Zhang J, Zhou L, Jiang Z, Chen J, He T.   +7 more
europepmc   +1 more source

Effect of Host Genetic Variation on the Pharmacokinetics and Clinical Response of Nnrtis

, 2007
Akihiko Saitoh, Stephen A. Spector
openalex   +2 more sources